John Gordan
Affiliations: | 2011-2016 | Cellular and Molecular Pharmacology | University of California, San Francisco, San Francisco, CA |
Google:
"John Gordan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lauer SM, Omar MH, Golkowski MG, et al. (2024) Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma. Cell Reports. 43: 113678 |
| Myint KZ, Sueca-Comes M, Collier P, et al. (2023) Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma. Frontiers in Oncology. 13: 1184900 |
| Lauer SM, Omar MH, Golkowski MG, et al. (2023) Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma. Biorxiv : the Preprint Server For Biology |
| Chan GKL, Maisel S, Hwang YC, et al. (2023) Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms. Elife. 12 |
| Wu Q, Zhen Y, Shi L, et al. (2022) EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma. Cancer Discovery. OF1-OF18 |
| Melnyk JE, Steri V, Nguyen HG, et al. (2022) Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. Oncogene |
| Coles GL, Cristea S, Webber JT, et al. (2020) Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Cancer Cell |
| El Dika I, Mayer RJ, Venook AP, et al. (2020) A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. The Oncologist |
| Wang J, Wang H, Peters M, et al. (2019) Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis. Journal of Hepatology |
| Lou K, Steri V, Ge AY, et al. (2019) KRAS inhibition produces a driver-limited state revealing collateral dependencies. Science Signaling. 12 |